Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Alpha Tau Medical Ltd DRTS

Alternate Symbol(s):  DRTSW

Healthcare Biotechnology
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical... see more

Recent & Breaking News (NDAQ:DRTS)

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 7, 2024

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

GlobeNewswire February 26, 2024

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 20, 2023

Alpha Tau to Participate in Sidoti Small-Cap Conference

GlobeNewswire November 29, 2023

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

GlobeNewswire November 28, 2023

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

GlobeNewswire November 20, 2023

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 16, 2023

Alpha Tau to Participate in November Investor Conferences

GlobeNewswire November 1, 2023

Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility

GlobeNewswire October 30, 2023

Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board

GlobeNewswire October 24, 2023

Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical Center

GlobeNewswire September 14, 2023

Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 28, 2023

Alpha Tau Medical to Participate in September Investor Conferences

GlobeNewswire August 24, 2023

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

GlobeNewswire August 17, 2023

Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023

GlobeNewswire August 2, 2023

Alpha Tau Medical to Participate in June Investor Conferences

GlobeNewswire May 24, 2023

Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 23, 2023

Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University

GlobeNewswire May 17, 2023

Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open

GlobeNewswire May 11, 2023

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day

GlobeNewswire May 3, 2023

Podcasts